5 citations
,
January 2024 in “BMC Cancer” In this descriptive study, researchers assessed the most common short-term side effects of anthracycline and taxane-based chemotherapy in 122 Moroccan women with localized breast cancer, documenting frequent systemic, gastrointestinal, dermatological, neurological, musculoskeletal, and ocular toxicities.
November 2024 in “Journal of the European Academy of Dermatology and Venereology” This study found that nearly 40% of patients with severe alopecia areata who showed eyebrow or eyelash regrowth on baricitinib 4 mg achieved significant scalp hair regrowth by the second year of treatment.
October 2023 in “Journal of food chemistry & nanotechnology” In this review, the authors highlighted the medicinal potential of Ziziphus jujuba seeds, emphasizing their antioxidant, antimicrobial, and anti-inflammatory properties, and called for further research to better understand their therapeutic effects and mechanisms.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, a herbal hair dye was formulated and tested, showing good stability and quality. The addition of Barleria prionitis flower enhanced color intensity and conditioning effects, suggesting it as a safe and effective natural alternative to chemical dyes.
December 2025 in “International Journal of Innovative Technologies in Social Science” This systematic review concluded that oral JAK inhibitors, such as baricitinib and deuruxolitinib, are effective and generally well-tolerated treatments for moderate-to-severe alopecia areata, offering advantages over traditional therapies.
August 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This product description details an ayurvedic herbomineral cream claimed to be for alopecia, listing its plant-based ingredients and the mineral supplement Yashad bhasma, but reports no new clinical results.
4 citations
,
October 2024 in “Journal of the American Academy of Dermatology” Abrocitinib may help treat alopecia areata effectively with mild side effects.
47 citations
,
February 2019 in “Asian Journal of Pharmaceutical and Clinical Research” This review discusses the chemical composition and traditional medicinal uses of Eruca sativa, particularly its potential applications in topical preparations for hair growth and treating skin infections, but reports no new clinical results.
5 citations
,
October 2022 in “British Journal of Dermatology” This study reports that two phase III trials demonstrated the effectiveness of the oral Janus kinase inhibitor baricitinib at 2 mg or 4 mg daily for treating severe alopecia areata in adults, marking a potential advance in managing this condition.
September 2021 in “International Ayurvedic Medical Journal” This study reported that in 31 patients with diffuse hair loss, daily application of Bhringraj oil significantly reduced hair fall, dandruff, itching, and dryness over four weeks, without any adverse reactions.
4 citations
,
January 2019 in “International journal of bioorganic chemistry” This study documented 64 medicinal plants used by local communities in Charmang, Pakistan, highlighting their potential significance for traditional medicine and future research on plant-derived therapies.
December 2025 in “Orvosi Hetilap” This study found that baricitinib is effective for treating severe alopecia areata, with significant hair regrowth observed by the third month of therapy and continued improvement by month 12, while adverse events were mainly mild.
January 2003 in “Linchuang pifuke zazhi” In this study, Zingiber coralliaum oil induced premature hair growth in mouse skin during tests, suggesting its potential for managing hair growth disorders.
4 citations
,
September 2022 in “Journal of The American Academy of Dermatology” This study examined phase 3 clinical trial data and found that baricitinib improves hair regrowth in adults with alopecia areata and significant scalp hair loss, with the response varying based on the severity of hair loss at the start of treatment.
March 2026 in “Tropical Journal of Natural Product Research” In this study, the bark extract of Albizia saponaria was analyzed for its metabolites and potential anti-alopecia effects, identifying several compounds with predicted affinities for proteins involved in hair loss pathways.
June 2010 in “Journal of Medicine and Life Science” This study suggests that Orostachys iwarenge extract may promote hair growth by increasing the proliferation of dermal papilla cells in an in-vitro setting.
May 2026 in “SKIN The Journal of Cutaneous Medicine” In this case report, a 60-year-old woman with alopecia areata and type 1 diabetes experienced hypoglycemic seizures after starting baricitinib, though reducing the dose alleviated these episodes; the study highlights the need for caution and glucose monitoring when using JAK inhibitors in at-risk patients.
February 2022 in “Indian Journal of Traditional Knowledge” In this study, a herbal oil formulation combining Hibiscus rosa-sinensis, Jasminum officinale, and Ficus benghalensis showed potential in reducing dandruff and promoting hair growth in affected individuals.
17 citations
,
April 2023 in “British Journal of Dermatology” This study suggests that off-label use of baricitinib in children under 12 with alopecia areata may improve hair regrowth, but further research is needed to confirm efficacy and safety.
January 2005 in “ScholarSpace (University of Hawaii at Manoa)” This project reports that Vitex rotundifolia may have cancer chemotherapeutic potential due to its ability to inhibit MAP kinase phosphorylation, suggesting further investigation into its active constituents.
74 citations
,
February 2018 in “Journal of the American Academy of Dermatology” 38 citations
,
September 2017 in “Journal of zoo and wildlife medicine” This study describes the successful management of Andean bear alopecia syndrome in three female bears using oclacitinib, leading to rapid pruritus resolution and fur regrowth without adverse effects.
November 2024 in “Journal of Cosmetic Dermatology” This study found that baricitinib, a Janus kinase inhibitor, was more effective than traditional treatments for severe alopecia areata, with higher rates of significant hair regrowth after 6 months, despite mild-to-moderate side effects and some instances of weight gain.
June 2026 in “International Journal of Plant & Soil Science” This narrative review examines the traditional uses and pharmacological properties of Eclipta alba, emphasizing its potential benefits like hepatoprotective and hair growth-promoting effects, but highlights the need for more clinical validation and a focus on preserving traditional knowledge.
9 citations
,
August 2014 in “Journal of The Korean Society of Food Science and Nutrition” This study found that Zizyphus jujuba, especially when fermented with Saccharomyces cerevisiae, showed strong antioxidative activity and effectively promoted hair regrowth and prevented hair loss in a mouse model.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers formulated a herbal hair dye with natural ingredients, including Barleria prionitis, and found it to be stable, effective, and a promising natural alternative to chemical dyes, enhancing color intensity and hair conditioning compared to formulations without this component.
12 citations
,
February 2022 in “Frontiers in Pharmacology” This study reports that Asparagus racemosus and Withania somnifera extracts significantly reduced paclitaxel-induced myelosuppression and morbidity in mice, suggesting their potential as therapeutic adjuvants in cancer management.
1 citations
,
June 2023 in “Ethnobotany research and applications” This review examined the medicinal properties of the Ziziphus plant species, highlighting their traditional use in treating various conditions and their bioactive compounds with potential anticancer, antimicrobial, and anti-diabetic effects. The authors concluded that Ziziphus species, particularly jujube, have promising pharmacological activities warranting further investigation.
November 2025 in “SKIN The Journal of Cutaneous Medicine” In this study on adolescents with severe alopecia areata, baricitinib treatment showed effective scalp, eyebrow, and eyelash regrowth after 52 weeks, benefiting both responders and partial or non-responders, potentially reducing the psychosocial impact of the disease.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, rosemary essential oil and banyan aerial roots were used to develop a hair serum aimed at addressing hair fall and dandruff, with evaluations showing successful determination of parameters like viscosity and pH.